100th つないで、進む FRONTIERS IN LIFE SCIENCE

検索の使い方

Lung Cancer Tissue Array, Including TNM, Clinical Stage And Pathology Grade, 48 Cases/96 Cores|ヒト組織アレイ

掲載日情報：2015/08/07 現在Webページ番号：173440

ティッシューアレイドットコム /
TissueArray.Com LLC
[メーカー略称：USB]

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Lung Cancer Tissue Array, Including TNM, Clinical Stage And Pathology Grade, 48 Cases/96 Cores)をご紹介します。

※ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
※ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
※本製品は研究用です。研究用以外には使用できません。

カートに商品を
追加しました。

ヒト組織アレイの価格

[在庫・価格 ：2024年06月06日 13時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
 納期 文献数
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores
  • お問い合わせ
 2～3週間 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
  • お問い合わせ
説明文
法規制等
保存条件 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして

[在庫・価格 ：2024年06月06日 13時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores

文献数： 0

  • お問い合わせ

説明文
法規制等
保存条件 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして
  • お問い合わせ

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイの特長

Microarray Panel: Lung squamous cell carcinoma tissue microarray, containing 12 cases of lung squamous cell carcinoma, 3 lung adenosquamous carcinoma, 2 lung bronchioloalveolar carcinoma, 12 lung adenocarcinoma, 3 lung small cell undifferentiated carcinoma, 1 each of lung atypical carcinoid, neuroendocrine carcinoma, metastatic squamous cell carcinoma, metastatic adenocaicinoma, pneumonoconiosis and pulmonary tuberculosis, 3 lung granulomatous inflammation, 4 lung pneumonia, plus 3 normal lung tissue, duplicate cores per case (duplicated cores from the same patient were put onto upper and lower rows in the same position)
Cores: 96
組織アレイ
Cases: 48
Layout: 12 cols × 8 rows
Core Diameter: 1.5 mm
Thickness: 5 µm
Quality Control: Anti-Actin confirmed
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 54 Lung Squamous cell carcinoma 1 IIIa T2N3M0 Malignant
A2 2 M 60 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
A3 3 M 63 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
A4 4 M 71 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
A5 5 M 56 Lung Squamous cell carcinoma 1 II T2N1M0 Malignant
A6 6 M 64 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
A7 7 M 55 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
A8 8 M 71 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
A9 9 M 52 Lung Squamous cell carcinoma 2 IIIb T4N1M0 Malignant
A10 10 F 61 Lung Squamous cell carcinoma 3 I T2N0M0 Malignant
A11 11 M 62 Lung Squamous cell carcinoma 3 I T2N0M0 Malignant
A12 12 M 61 Lung Squamous cell carcinoma 3 I T2N0M0 Malignant
B1 13 M 54 Lung Squamous cell carcinoma 1 IIIa T2N3M0 Malignant
B2 14 M 60 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
B3 15 M 63 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
B4 16 M 71 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
B5 17 M 56 Lung Squamous cell carcinoma 1 II T2N1M0 Malignant
B6 18 M 64 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
B7 19 M 55 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
B8 20 M 71 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
B9 21 M 52 Lung Squamous cell carcinoma 2 IIIb T4N1M0 Malignant
B10 22 F 61 Lung Squamous cell carcinoma 3 I T2N0M0 Malignant
B11 23 M 62 Lung Squamous cell carcinoma 3 I T2N0M0 Malignant
B12 24 M 61 Lung Squamous cell carcinoma 3 I T2N0M0 Malignant
C1 25 M 70 Lung Adenosquamous carcinoma – I T2N0M0 Malignant
C2 26 F 67 Lung Adenosquamous carcinoma – I T2N1M0 Malignant
C3 27 M 70 Lung Adenosquamous carcinoma – I T2N0M0 Malignant
C4 28 F 74 Lung Bronchioloalveolar carcinoma – I T2N0M0 Malignant
C5 29 F 48 Lung Bronchioloalveolar carcinoma – I T2N0M0 Malignant
C6 30 M 58 Lung Adenocarcinoma 3 II T2N1M0 Malignant
C7 31 M 62 Lung Adenocarcinoma (pneumonia) – I T2N0M0 Malignant
C8 32 M 64 Lung Adenocarcinoma 3 I T2N0M0 Malignant
C9 33 M 58 Lung Adenocarcinoma 3 I T2N0M0 Malignant
C10 34 F 45 Lung Adenocarcinoma 3 IIIb T4N0M0 Malignant
C11 35 F 39 Lung Adenocarcinoma 3 I T2N0M0 Malignant
C12 36 M 49 Lung Mucinous adenocarcinoma 2 I T2N0M0 Malignant
D1 37 M 70 Lung Adenosquamous carcinoma – I T2N0M0 Malignant
D2 38 F 67 Lung Adenosquamous carcinoma – I T2N1M0 Malignant
D3 39 M 70 Lung Adenosquamous carcinoma – I T2N0M0 Malignant
D4 40 F 74 Lung Bronchioloalveolar carcinoma – I T2N0M0 Malignant
D5 41 F 48 Lung Bronchioloalveolar carcinoma – I T2N0M0 Malignant
D6 42 M 58 Lung Adenocarcinoma 3 II T2N1M0 Malignant
D7 43 M 62 Lung Adenocarcinoma 3 I T2N0M0 Malignant
D8 44 M 64 Lung Adenocarcinoma 3 I T2N0M0 Malignant
D9 45 M 58 Lung Adenocarcinoma 3 I T2N0M0 Malignant
D10 46 F 45 Lung Adenocarcinoma 3 IIIb T4N0M0 Malignant
D11 47 F 39 Lung Adenocarcinoma 3 I T2N0M0 Malignant
D12 48 M 49 Lung Mucinous adenocarcinoma 2 I T2N0M0 Malignant
E1 49 M 65 Lung Papillary adenocarcinoma 2 I T2N0M0 Malignant
E2 50 F 66 Lung Papillary adenocarcinoma 2 I T2N0M0 Malignant
E3 51 M 64 Lung Papillary adenocarcinoma 2 I T2N0M0 Malignant
E4 52 M 62 Lung Undifferentiation adenocarcinoma – II T2N1M0 Malignant
E5 53 M 51 Lung Undifferentiation adenocarcinoma – IIIa T3N2M0 Malignant
E6 54 M 36 Lung Small cell undifferentiated carcinoma – IIIa T2N2M0 Malignant
E7 55 M 72 Lung Small cell undifferentiated carcinoma – I T1N0M0 Malignant
E8 56 M 41 Lung Small cell undifferentiated carcinoma – IIIb T4N2M0 Malignant
E9 57 M 67 Lung Atypical carcinoid – I T2N0M0 Malignant
E10 58 M 46 Lung Neuroendocrine carcinoma – I T2N0M0 Malignant
E11 59 M 59 Lymph node Metastatic squamous cell carcinoma from lung 3 – – Metastasis
E12 60 F 68 Lymph node Metastatic adenocarcinoma from lung 3 – – Metastasis
F1 61 M 65 Lung Papillary adenocarcinoma 2 I T2N0M0 Malignant
F2 62 F 66 Lung Papillary adenocarcinoma 2 I T2N0M0 Malignant
F3 63 M 64 Lung Papillary adenocarcinoma 2 I T2N0M0 Malignant
F4 64 M 62 Lung Undifferentiation adenocarcinoma (chronic inflammation of fibrous tissue and blood vessel) – II T2N1M1 Malignant
F5 65 M 51 Lung Undifferentiation adenocarcinoma – IIIa T3N2M1 Malignant
F6 66 M 36 Lung Small cell undifferentiated carcinoma – IIIa T2N2M1 Malignant
F7 67 M 72 Lung Small cell undifferentiated carcinoma – I T1N0M1 Malignant
F8 68 M 41 Lung Small cell undifferentiated carcinoma – IIIb T4N2M1 Malignant
F9 69 M 67 Lung Atypical carcinoid – I T2N0M0 Malignant
F10 70 M 46 Lung Neuroendocrine carcinoma – I T2N0M0 Malignant
F11 71 M 59 Lymph node Metastatic squamous cell carcinoma from lung 3 – – Metastasis
F12 72 F 68 Lymph node Metastatic adenocarcinoma from lung 3 – – Metastasis
G1 73 M 68 Lung Pneumonoconiosis – – – Inflammation
G2 74 M 46 Lung Pulmonary tuberculosis – – – Inflammation
G3 75 M 26 Lung Granulomatous inflammation – – – Inflammation
G4 76 F 63 Lung Granulomatous inflammation – – – Inflammation
G5 77 M 53 Lung Granulomatous inflammation (normal lung tissue) – – – Inflammation
G6 78 M 51 Lung Pneumonia (normal lung tissue) – – – Inflammation
G7 79 M 42 Lung Interstitial pneumonia – – – Inflammation
G8 80 F 39 Lung Pneumonia – – – Inflammation
G9 81 F 60 Lung Interstitial pneumonia (normal lung tissue) – – – Inflammation
G10 82 M 47 Lung Normal lung tissue – – – Normal
G11 83 M 46 Lung Normal lung and bronchus tissue – – – Normal
G12 84 M 25 Lung Normal lung tissue – – – Normal
H1 85 M 68 Lung Pneumonoconiosis – – – Inflammation
H2 86 M 46 Lung Pulmonary tuberculosis – – – Inflammation
H3 87 M 26 Lung Granulomatous inflammation (normal lung tissue) – – – Inflammation
H4 88 F 63 Lung Granulomatous inflammation – – – Inflammation
H5 89 M 53 Lung Granulomatous inflammation – – – Inflammation
H6 90 M 51 Lung Pneumonia – – – Inflammation
H7 91 M 42 Lung Interstitial pneumonia (normal lung tissue) – – – Inflammation
H8 92 F 39 Lung Pneumonia (normal lung tissue) – – – Inflammation
H9 93 F 60 Lung Interstitial pneumonia – – – Inflammation
H10 94 M 47 Lung Normal lung and bronchus tissue – – – Normal
H11 95 M 46 Lung Normal lung tissue – – – Normal
H12 96 M 25 Lung Normal lung tissue – – – Normal
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイのFAQ

US BIOMAX社ヒト組織アレイのFAQはこちら。

目次に戻る

カートに商品を
追加しました。

お問い合わせ先

（テクニカルサポート 試薬担当）

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。